Australia In-vitro Diagnostics Market - Growth, Trends & Forecast (2019 - 2024)

The Australia In-vitro Diagnostics market is segmented by Techniques, Type of Products (Instruments, Reagents, Data Management Systems) Applications, and End User.

Market Snapshot

Australia In-vitro Diagnostics-1
Study Period:

2016-2024

Base Year:

2018

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The Australian in-vitro diagnostics market is believed to witness a CAGR of around 5.36% over the forecast period. Certain factors driving the market are an increase in the incidences of chronic and infectious diseases, a growing geriatric population, technological advances that are taking place in the diagnostic sector, and the advent of point of care diagnostics.

According to the Australian Institute of Health & Welfare (AIHW), around 3.7 million Australians (15% of the population) were aged 65 years and above in 2016. With an increasing geriatric population, there will be a growth of the typical age-related health problems (for example, arthritis, dementia, and cancer). As per the Australian Health Survey (AHS) 2015, 1 in 5 of the elderly population people (22%) reported being affected by cardiovascular diseases, while 15% had diabetes, and 7% had cancer. The trend of rising chronic diseases is increasing in the country; with such increase in incidences of chronic diseases, there is a need for diagnostic tests that provide critical insights at every stage of medical care, including prevention, detection, diagnosis, treatment, and successful management of health conditions. Therefore, it is believed that rising chronic incidences of diseases are driving the market of in-vitro diagnostics in Australia. 

Scope of the Report

As per the scope of this report, in-vitro diagnostics involves medical devices and consumables that are utilized to perform in-vitro tests on various biological samples. They are used for the diagnosis of various medical conditions and chronic diseases. In this report, a detailed analysis of the in-vitro diagnostics market is presented, with specific attention toward diabetes and thalassemia.

By Technique
Immunology
Hematology
Clinical Chemistry
Molecular Diagnostics
Coagulation
Microbiology
Other Techniques
By Type of product
Instruments
Reagents
Data Management Systems
By Applications
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
Other Applications
By End User
Laboratory
Hospitals
Point of Care Testing
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Reagent Segment is expected to have the Largest Market Share During the Forecast Period

The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, or preparations intended by the manufacturer to be used during the in-vitro diagnosis process.

Reagent usage for IVD kits often carries high costs. Nevertheless, a variety of new measures to counter this problem have emerged, which include, bulk purchase of reagents and local development and production of assay systems. Being a developed economy, Australia has established local immunoassay reagent programs to manufacture low-cost, high-quality immunoassay reagents. Kits from these projects are now gradually becoming available and are likely to fuel the market expansion.

Australia In-vitro Diagnostics-2

To understand key trends, Download Sample Report

Competitive Landscape

The Australian in-vitro diagnostics market is moderately competitive. Some of the major players of this market are BioMerieux, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Abbott. The major players hold most of the market share. With technological advances and product innovations, some small companies are also entering the market, currently holding a substantial market share.

Major Players

  1. bioMérieux SA
  2. F. Hoffmann-La Roche Ltd
  3. Becton, Dickinson and Company
  4. Bio-Rad Laboratories, Inc.
  5. Abbott

* Complete list of players covered available in the table of contents below

Australia In-vitro Diagnostics-3

Download the market shares of key players in this industry.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

      3. 4.2.3 Advanced Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technique

      1. 5.1.1 Immunology

      2. 5.1.2 Hematology

      3. 5.1.3 Clinical Chemistry

      4. 5.1.4 Molecular Diagnostics

      5. 5.1.5 Coagulation

      6. 5.1.6 Microbiology

      7. 5.1.7 Other Techniques

    2. 5.2 By Type of product

      1. 5.2.1 Instruments

      2. 5.2.2 Reagents

      3. 5.2.3 Data Management Systems

    3. 5.3 By Applications

      1. 5.3.1 Infectious Disease

      2. 5.3.2 Diabetes

      3. 5.3.3 Cancer/Oncology

      4. 5.3.4 Cardiology

      5. 5.3.5 Autoimmune Disease

      6. 5.3.6 Nephrology

      7. 5.3.7 Drug Testing

      8. 5.3.8 Other Applications

    4. 5.4 By End User

      1. 5.4.1 Laboratory

      2. 5.4.2 Hospitals

      3. 5.4.3 Point of Care Testing

      4. 5.4.4 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 BioMerieux

      2. 6.1.2 F. Hoffmann-La Roche Ltd

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Abbott

      6. 6.1.6 Siemens AG

      7. 6.1.7 Thermo Fisher Scientific

      8. 6.1.8 QIAGEN

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information